Literature DB >> 24557049

Searching for the immune basis of obsessive-compulsive disorder.

Antonio Lucio Teixeira1, David Henrique Rodrigues, Andrea Hovarth Marques, Eurípedes C Miguel, Leonardo F Fontenelle.   

Abstract

The etiopathogenesis of obsessive-compulsive disorder (OCD) remains elusive. Clinical observation of the elevated frequency of obsessive-compulsive symptoms in patients with rheumatic fever, a post-streptococcal autoimmune disease, prompted the study of immune parameters in OCD. Anti-basal ganglia antibodies have been described in a subset of OCD patients. The assessment of circulating cytokines and immune cells confirmed unequivocal changes in at least some patients, although it is difficult to establish a particular immune profile in OCD. Several factors, including the use of psychotropic drugs and the presence of comorbid conditions, seem to influence these immune parameters.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24557049     DOI: 10.1159/000356554

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  11 in total

1.  Immune Aberrations in Obsessive-Compulsive Disorder: a Systematic Review and Meta-analysis.

Authors:  Theodore D Cosco; Toby Pillinger; Hadeer Emam; Marco Solmi; Sanjay Budhdeo; A Matthew Prina; Michael Maes; Dan J Stein; Brendon Stubbs; Andre F Carvalho
Journal:  Mol Neurobiol       Date:  2018-10-31       Impact factor: 5.590

2.  Microribonucleic acid dysregulations in children and adolescents with obsessive-compulsive disorder.

Authors:  Hasan Kandemir; Mehmet Emin Erdal; Salih Selek; Özlem İzci Ay; İbrahim Fatih Karababa; Mustafa Ertan Ay; Sultan Basmacı Kandemir; Şenay Görücü Yılmaz; Suat Ekinci; Bahar Taşdelen; Hüseyin Bayazit
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-14       Impact factor: 2.570

Review 3.  Microglial Dysregulation in OCD, Tourette Syndrome, and PANDAS.

Authors:  Luciana Frick; Christopher Pittenger
Journal:  J Immunol Res       Date:  2016-12-07       Impact factor: 4.818

4.  Temporal Association of Certain Neuropsychiatric Disorders Following Vaccination of Children and Adolescents: A Pilot Case-Control Study.

Authors:  Douglas L Leslie; Robert A Kobre; Brian J Richmand; Selin Aktan Guloksuz; James F Leckman
Journal:  Front Psychiatry       Date:  2017-01-19       Impact factor: 4.157

5.  Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder.

Authors:  Natalia Rodríguez; Astrid Morer; E Azucena González-Navarro; Carles Serra-Pages; Daniel Boloc; Teresa Torres; Susana García-Cerro; Sergi Mas; Patricia Gassó; Luisa Lázaro
Journal:  J Neuroinflammation       Date:  2017-12-28       Impact factor: 8.322

Review 6.  Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder.

Authors:  Zoya Marinova; De-Maw Chuang; Naomi Fineberg
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 7.  Diagnostic Issues in Early-Onset Obsessive-Compulsive Disorder and their Treatment Implications.

Authors:  Elisabetta Burchi; Stefano Pallanti
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

8.  Association of Pediatric Acute-Onset Neuropsychiatric Syndrome With Microstructural Differences in Brain Regions Detected via Diffusion-Weighted Magnetic Resonance Imaging.

Authors:  Jimmy Zheng; Jennifer Frankovich; Emily S McKenna; Nathan C Rowe; Sarah J MacEachern; Nathan N Ng; Lydia T Tam; Peter K Moon; Jaynelle Gao; Margo Thienemann; Nils D Forkert; Kristen W Yeom
Journal:  JAMA Netw Open       Date:  2020-05-01

9.  Anti-NMDAR antibodies as a new piece in schizophrenia's puzzle.

Authors:  Antonio L Teixeira; Natalia P Rocha; Xiang Zhang
Journal:  Future Sci OA       Date:  2017-03-03

10.  Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors.

Authors:  Mario Gennaro Mazza; Rebecca De Lorenzo; Caterina Conte; Sara Poletti; Benedetta Vai; Irene Bollettini; Elisa Maria Teresa Melloni; Roberto Furlan; Fabio Ciceri; Patrizia Rovere-Querini; Francesco Benedetti
Journal:  Brain Behav Immun       Date:  2020-07-30       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.